Pneumology - Original Articles
19 June 2025

Use of a novel ultrasound sign in the management of malignant pleural effusions: a prospective observational trial

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
29
Views
15
Downloads

Authors

The management of malignant pleural effusion (MPE) is influenced by the lung’s ability to re-expand following fluid drainage. Lung entrapment can complicate this process and may be predicted using pleural manometry. Recently, a novel lung ultrasound (LUS) marker—the sinusoidal sign—has emerged as a potential tool to differentiate between expandable and entrapped lung prior to thoracentesis. A prospective observational study was conducted to evaluate the role of pre-drainage LUS in identifying entrapped lung and compare its diagnostic accuracy with pleural manometry. A total of 30 patients with MPE were enrolled. Prior to thoracentesis, targeted ipsilateral LUS was performed at the level of the atelectatic lung. M-mode displacement <1 mm was considered indicative of an absent sinusoidal sign. Simultaneously, pleural manometry was conducted during thoracentesis to measure pressure changes and calculate pleural elastance. Lung expandability was determined based on pleural elastance and post-thoracentesis imaging findings (computed tomography thorax). A pleural elastance >13.6 cm H₂O/L was considered diagnostic of lung entrapment. A pleural elastance cut-off of 13.6 cm H₂O/L demonstrated 100% sensitivity, 93% specificity, a 100% positive predictive value, and 84.2% negative predictive value. The absence of the sinusoidal sign on LUS had a sensitivity of 78.6% and specificity of 100% in identifying entrapped lung. Both absent sinusoidal sign on pre-drainage LUS and elevated pleural elastance (>13.6 cm H₂O/L) during thoracentesis are reliable indicators of lung entrapment in MPE. LUS may serve as a useful, non-invasive bedside tool for early identification of non-expandable lung.

Altmetrics

Downloads

Download data is not yet available.

Citations

Porcel JM, Gasol A, Bielsa S, et al. Clinical features and survival of lung cancer patients with pleural effusions. Respirology 2015;20:654-9. DOI: https://doi.org/10.1111/resp.12496
Mongardon N, Pinton-Gonnet C, Szekely B, et al. Assessment of chronic pain after thoracotomy: a 1-year prevalence study. Clin J Pain 2011;27:677-81. DOI: https://doi.org/10.1097/AJP.0b013e31821981a3
Johnston WW. The malignant pleural effusion: a review of cytopathologic diagnoses of 584 specimens from 472 consecutive patients. Cancer 1985;56:905-9. DOI: https://doi.org/10.1002/1097-0142(19850815)56:4<905::AID-CNCR2820560435>3.0.CO;2-U
Ost DE, Niu J, Zhao H, et al. Quality gaps and comparative effectiveness of management strategies for recurrent malignant pleural effusions. Chest 2018;153:438-52. DOI: https://doi.org/10.1016/j.chest.2017.08.026
Feller-Kopman DJ, Reddy CB, De Camp MM, et al. Management of malignant pleural effusions. An official ATS/STS/STR clinical practice guideline. Am J Respir Crit Care Med 2018;198:839-49. DOI: https://doi.org/10.1164/rccm.201807-1415ST
Antony VB, Loddenkemper R, Astoul P, et al. Management of malignant pleural effusions. Am J Respir Crit Care Med 2000;162:1987-2001. DOI: https://doi.org/10.1164/ajrccm.162.5.ats8-00
Naito T, Satoh H, Ishikawa H, et al. Pleural effusion as a significant prognostic factor in non-small cell lung cancer. Anticancer Res 1997;17:4743-6.
Lan RS, Lo SK, Chuang ML, et al. Elastance of the pleural space: a predictor for the outcome of pleurodesis in patients with malignant pleural effusion. Ann Intern Med 1997;126:768-74. DOI: https://doi.org/10.7326/0003-4819-126-10-199705150-00003
Wong A, Patail H, Ahmad S. The absent sinusoid sign. Ann Am Thorac Soc 2019;16:506-8. DOI: https://doi.org/10.1513/AnnalsATS.201810-654CC
Taghizadeh N, Fortin M, Tremblay A. US hospitalizations for malignant pleural effusions: data from the 2012 national inpatient sample. Chest 2017;151:845-54. DOI: https://doi.org/10.1016/j.chest.2016.11.010
Roberts ME, Neville E, Berrisford RG, et al. Management of a malignant pleural effusion: British Thoracic Society pleural disease guideline 2010. Thorax 2010;65:32-40. DOI: https://doi.org/10.1136/thx.2010.136994
Huggins JT, Sahn SA, Heidecker J, et al. Characteristics of trapped lung: pleural fluid analysis, manometry, and air-contrast chest CT. Chest 2007;131: 206-13. DOI: https://doi.org/10.1378/chest.06-0430
Hu K, Chopra A, Huggins JT, Nanchal R. Pleural manometry: techniques, applications, and pitfalls. J Thorac Dis 2020;12:2759-70. DOI: https://doi.org/10.21037/jtd.2020.04.04
Martin GA, Tsim S, Kidd AC, et al. Pre-EDIT: a randomized feasibility trial of Elastance-Directed intrapleural catheter or talc pleurodesis in malignant pleural effusion. Chest 2019;156:1204-13. DOI: https://doi.org/10.1183/13993003.congress-2018.OA495
Light RW, Jenkinson SG, Minh VD, George RB. Observations on pleural fluid pressures as fluid is withdrawn during thoracentesis. Am Rev Respir Dis 1980;121:799-804.
Feller-Kopman D. Therapeutic thoracentesis: the role of ultrasound and pleural manometry. Curr Opin Pulm Med 2007;13:312-8. DOI: https://doi.org/10.1097/MCP.0b013e3281214492
Salamonsen MR, Lo AK, Ng AC, et al. Novel use of pleural ultrasound can identify malignant entrapped lung prior to effusion drainage. Chest 2014;146:1286-93. DOI: https://doi.org/10.1378/chest.13-2876
Singh N, Agrawal S, Jiwnani S, et al. Lung cancer in India. J Thorac Oncol 2021;16:1250-66. DOI: https://doi.org/10.1016/j.jtho.2021.02.004
Mohan A, Garg A, Gupta A, et al. Clinical profile of lung cancer in North India: A 10-year analysis of 1862 patients from a tertiary care center. Lung India 2020;37:190-7. DOI: https://doi.org/10.4103/lungindia.lungindia_333_19
Malik PS, Sharma MC, Mohanti BK, et al. Clinico-pathological profile of lung cancer at AIIMS: A changing paradigm in India. Asian Pac J Cancer Prev 2013;14:489-94. DOI: https://doi.org/10.7314/APJCP.2013.14.1.489
Feller-Kopman D, Walkey A, Berkowitz D, Ernst A. The relationship of pleural pressure to symptom development during therapeutic thoracentesis. Chest 2006;129:1556-60. DOI: https://doi.org/10.1378/chest.129.6.1556
Chopra A, Judson MA, Doelken P, et al. The relationship of pleural manometry with post thoracentesis chest radiographic findings in malignant pleural effusion. Chest 2020;157:421-6. DOI: https://doi.org/10.1016/j.chest.2019.08.1920

Ethics Approval

Ethics approval was obtained from the All India Institute of Medical Sciences, Jodhpur, India. Approval number: AIIMS/IEC/2020/3318.

How to Cite



“Use of a Novel Ultrasound Sign in the Management of Malignant Pleural Effusions: A Prospective Observational Trial”. 2025. Monaldi Archives for Chest Disease, June. https://doi.org/10.4081/monaldi.2025.3263.